As an important regulatory factor in tumors, PGRN is strongly expressed in various tumors, including cervical cancer, prostate cancer, bladder cancer, colorectal cancer, and lymphoma, and is associated with overall survival [27, , , -31]. This evidence concerns the gene GRN and colorectal cancer.